Results 191 to 200 of about 14,397,534 (393)

Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing [PDF]

, 2002
Sven Zedlitz, Lars Linzbach, Roland Kaufmann, Wolf‐­Henning Boehncke   +3 more
openalex   +1 more source

Multi‐omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma

Molecular Oncology, EarlyView.
Using multi‐omic characterization, we aimed to identify key regulators specific to squamous cell lung carcinoma (SqCC). SqCC‐specific differentially expressed genes were integrated with metabolics data. High expression of the creatine transporter SLC6A8, along with elevated creatine levels, appeared to be a distinct metabolic feature of SqCC.
Johan Staaf, Daniel Ehinger, Hans Brunnström, Mats Jönsson, Frida Rosengren, Marija Kotevska, Anna Karlsson, Mattias Aine, Christian Frezza, Maria Planck, Elsa Arbajian   +10 more
wiley   +1 more source

Evaluation of Artificial Intelligence-Assisted Diagnosis of Skin Erythema in a Patch Test. [PDF]

Contact Dermatitis
Kim S, Hwang H, Oh M, Han J, Park S, Lee S, Kim G, Cho S, Lee DH, Cho JY.   +9 more
europepmc   +1 more source

Predictive factors for Day 7 positive patch test readings at a secondary referral centre. [PDF]

Skin Health Dis, 2022
Tupker RA, Stapper WGC, Kelder JC.
europepmc   +1 more source

Clutter sensitivity test under controlled field conditions Resonant Microstrip Patch Antenna (RMPA) sensor technology

, 1996

openalex   +2 more sources

Patch Testing with European Standard Allergens in Tunisian Patients [PDF]

, 2002
Slaheddine Marrakchi, H. Turki, Mohamed Hammami, Abdelmajid Zahaf   +3 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Evaluating the Efficacy of Soothing Agents in Mitigating 0.1% Retinol-Induced Skin Irritation: A Patch Test. [PDF]

J Cosmet Dermatol
Ying Y, Fang Y, Chenlan X, Lin S, Jiefang H, Yanan L, Peiwen S.   +6 more
europepmc   +1 more source

A case of bortezomib (Velcade)-induced Stevens-Johnson syndrome confirmed by patch test. [PDF]

Asia Pac Allergy, 2021
Choi GS, Lee HS, Kim HK.
europepmc   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source